149 related articles for article (PubMed ID: 34393714)
1. Molecular Alterations and Their Correlation With the Survival of Glioblastoma Patients With Corpus Callosum Involvement.
Cui M; Gao X; Chi Y; Zhang M; Lin H; Chen H; Sun C; Ma X
Front Neurosci; 2021; 15():701426. PubMed ID: 34393714
[No Abstract] [Full Text] [Related]
2. Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum.
Cui M; Chen H; Sun G; Liu J; Zhang M; Lin H; Sun C; Ma X
Acta Neurochir (Wien); 2022 Mar; 164(3):689-702. PubMed ID: 34636967
[TBL] [Abstract][Full Text] [Related]
3. Applying the en-bloc technique in corpus callosum glioblastoma surgery contributes to maximal resection and better prognosis: a retrospective study.
Que T; Yuan X; Tan JE; Zheng H; Yi G; Li Z; Wang X; Liu J; Xu H; Wang Y; Zhang XA; Huang G; Qi S
BMC Surg; 2024 Jan; 24(1):4. PubMed ID: 38166900
[TBL] [Abstract][Full Text] [Related]
4. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
[TBL] [Abstract][Full Text] [Related]
5. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
6. The role of
Dono A; Ramesh AV; Wang E; Shah M; Tandon N; Ballester LY; Esquenazi Y
Neurooncol Adv; 2021; 3(1):vdab050. PubMed ID: 34131647
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma.
Park C; Kim TM; Bae JM; Yun H; Kim JW; Choi SH; Lee ST; Lee JH; Park SH; Park CK
Cancer Res Treat; 2021 Apr; 53(2):389-398. PubMed ID: 33171023
[TBL] [Abstract][Full Text] [Related]
8. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients.
Chaddad A; Sabri S; Niazi T; Abdulkarim B
Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
10. Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study.
Monk BJ; Ghatage P; Parekh T; Henitz E; Knoblauch R; Matos-Pita AS; Nieto A; Park YC; Cheng PS; Li W; Favis R; Ricci D; Poveda A
Ann Oncol; 2015 May; 26(5):914-920. PubMed ID: 25722380
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
[TBL] [Abstract][Full Text] [Related]
12. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
An G; Ahn S; Park JS; Jeun SS; Hong YK
J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
[TBL] [Abstract][Full Text] [Related]
13. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
Mistry AM; Hale AT; Chambless LB; Weaver KD; Thompson RC; Ihrie RA
J Neurooncol; 2017 Jan; 131(1):125-133. PubMed ID: 27644688
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?
Soike MH; McTyre ER; Shah N; Puchalski RB; Holmes JA; Paulsson AK; Miller LD; Cramer CK; Lesser GJ; Strowd RE; Hinson WH; Mott RT; Johnson AJ; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
Neuroradiology; 2018 Oct; 60(10):1043-1051. PubMed ID: 30094640
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
Lu VM; O'Connor KP; Shah AH; Eichberg DG; Luther EM; Komotar RJ; Ivan ME
J Neurooncol; 2020 Jun; 148(2):221-229. PubMed ID: 32385699
[TBL] [Abstract][Full Text] [Related]
16. Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
Shieh LT; Guo HR; Ho CH; Lin LC; Chang CH; Ho SY
PLoS One; 2020; 15(5):e0233188. PubMed ID: 32413077
[TBL] [Abstract][Full Text] [Related]
17. Associations of histological and molecular alterations with invasion of the corpus callosum in gliomas.
Shen S; Feng S; Liu H; Jiang J; Yu X
Acta Neurochir (Wien); 2020 Jul; 162(7):1691-1699. PubMed ID: 32440925
[TBL] [Abstract][Full Text] [Related]
18. Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.
Pasqualetti F; Orlandi P; Simeon V; Cantarella M; Giuliani D; Di Desidero T; Gonnelli A; Delishaj D; Lombardi G; Sechi A; Sanson M; Zagonel V; Paiar F; Danesi R; Guarini S; Bocci G
Mol Neurobiol; 2018 Feb; 55(2):1396-1404. PubMed ID: 28150230
[TBL] [Abstract][Full Text] [Related]
19. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
[TBL] [Abstract][Full Text] [Related]
20. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
